NFKB1 and acute myeloid leukemia: The proteasome inhibitor, MG-132, inhibited NF-κB activation through stabilization of its cellular inhibitor, IκB and was able to induce apoptosis in CD34+CD38- AML cells while sparing normal progenitors.